We’re partnering with Randox to bring sovereign technology to healthcare
Valarian partners with Randox, the UK’s largest diagnostics company, beginning with Randox’s manufacturing operations before expanding into healthcare in December.
- Major deal sees British technology firm Valarian partner with global diagnostics company Randox, whose products are used in the diagnosis of over 400 million people worldwide each year
- Partnership will begin with securing Randox’s manufacturing operations before expanding into healthcare in December
- Agreement comes amid growing focus on strengthening Britain’s sovereign technology capabilities
British technology company Valarian has struck a major multi-year deal with global diagnostics giant Randox to deliver sovereign healthcare technology, marking a significant move into healthcare for the London-headquartered firm.
Under the agreement, Randox will deploy its data and analysis into Valarian’s secure digital architecture, initially focusing on manufacturing before expanding into healthcare in December. Acting as a sovereign execution layer, Valarian’s ACRA technology allows organisations to securely use and manage sensitive data without relinquishing ownership or control to external providers.
By the end of the year, the two British companies aim to deliver a comprehensive sovereign healthcare solution, combining Randox’s global expertise in diagnostics with Valarian’s secure infrastructure to support the use of advanced technology while keeping sensitive information protected and under organisational control.
Founded in Northern Ireland, Randox is the UK’s largest diagnostics company and a major player in global healthcare. Its technologies help healthcare providers detect and manage disease, with the company manufacturing more than four billion tests annually and its products used in the diagnosis of over 400 million people worldwide each year.
Max Buchan, CEO and founder of Valarian, said:
“We’ve had the pleasure of working with Will McManners and MD One since the early days of Valarian. I can honestly say that Will’s been one of the most outstanding investors we’ve had on the journey. Through him, we met Randox and started to collaborate both on securing critical AI systems while also planning how to help the NHS at scale.
“Britain has some of the best technology and healthcare companies in the world. Randox is a fantastic example of that, and I’m proud to be partnering with another UK business to help secure the sensitive data underpinning our healthcare sector.
“This agreement marks a major step forward for Valarian and shows what British companies can achieve together. It also shows what's possible with great investors, like MD One, that believe that Britain can build the best in the world and are there to connect the companies that can do it.
“Britain has the talent and expertise in this country to deliver world-class technology, and partnerships like this demonstrate why we should be backing British businesses to secure the infrastructure our most important services depend on.”
Joseph Clifford, Chief Technical Officer of Randox, said:
“We’re entrusted with a large amount of patient data, and our patients are of the utmost importance to us. Ensuring their data is secure is first and foremost, and we’ve seen the Valarian product as a key fit for peace of mind in that area.”
For Valarian, the agreement builds on its growing international presence. The company provides secure digital infrastructure to organisations across government, defence and enterprise, with its core platform, ACRA, enabling organisations to deploy advanced AI while keeping sensitive data securely within their own environments.
Its technology is already deployed across four continents, and in July the company raised a $50 million Series A led by NEA to support its continued expansion.
News comes amid growing scrutiny of how sensitive healthcare data is accessed and protected. Earlier this month, OpenAI executives appeared before an Australian parliamentary inquiry following unauthorised access to government websites, including Medicare statistical data, raising fresh questions about how healthcare information is protected from external access.
These concerns coincide with a wider push to strengthen Britain’s domestic technology capabilities. At Labour Party Conference, First Secretary of State Louise Haigh committed to “building our sovereign capabilities and backing our own incredible tech sector”.
